Novel cyclic phosphoramidate prodrugs of parent drugs MH of formula I
their use in delivery of drugs to the liver, their use in enhancing oral bioavailability, and their method of preparation are described.
Novel cyclic phosphoramidate prodrugs of drugs of formula I
their use in delivery of drugs to the liver, their use in enhancing oral bioavailability, and their method of preparation are described.
Novel cyclic phosphoramidate prodrugs of drugs of formula I
their use in delivery of drugs to the liver, their use in enhancing oral bioavailability, and their method of preparation are described.
Novel cyclic phosphoramidate prodrugs of drugs of formula I
their use in delivery of drugs to the liver, their use in enhancing oral bioavailability, and their method of preparation are described.